Exosomes & CTCs
Dedicated solutions for exosome and CTC isolation stabilize your signal of interest
Exosomes and circulating tumor cells (CTCs) are components of liquid biopsies that have huge potential. But wide adoption has been hindered by a general lack of standardized, robust sample preparation solutions for exosome purification and CTC isolation.
Standardized sample processing for exosome and CTC purification is a crucial factor in your liquid biopsy investigations. Our dedicated solutions for isolation of extracellular vesicles (EVs) and CTCs reduce background and stabilize your signal of interest.
閲覧 Exosomes & CTCs
製品
Sort
Application
Handling
Sample type
Starting material
Format
Instrument
12個の製品が見つかりました
exoEasy Maxi Kit
血清、血漿、細胞培養上清からのインタクトなエクソソームや細胞外小胞（extracellular vesicles: EVs）の精製
exoRNeasy Serum/Plasma Kits
血清、血漿、細胞培養上清からのエクソソームや細胞外小胞（extracellular vesicles:EVs）中のRNA精製
miRCURY LNA miRNA Focus PCR Panels
LNA-エンハンスドmiRNAqPCRによる高感度・特異的miRNAプロファイリング
AdnaTest ProstateCancer
For the enrichment and molecular characterization of circulating tumor cells (CTCs) from whole human blood
miRCURE Exosome Kits
血清／血漿または細胞／尿／脳脊髄液サンプルからエキソソームや細胞外小胞の濃縮
AdnaTest ProstateCancerPanel AR-V7
For the enrichment and molecular characterization of circulating tumor cells (CTCs) from whole human blood
AdnaTest EMT-2/StemCell
RT-PCR kit for detection of gene expression in enriched tumor cells associated with epithelial-mesenchymal transition and cancer cell stemness.
AdnaTest LungCancer
For the enrichment and molecular characterization of circulating tumor cells (CTCs) from whole human blood.
AdnaTest BreastCancer
For the enrichment and molecular characterization of circulating tumor cells (CTCs) from whole human blood
AdnaTest ColonCancer
For the enrichment and molecular characterization of circulating tumor cells (CTCs) from whole human blood
AllPrep DNA/mRNA Nano Kit
For the simultaneous purification of genomic DNA (gDNA) and messenger RNA (mRNA) from low-biomass samples
EZ2 AdnaTest CTC Select Kit
For automated immunomagnetic enrichment and integrated mRNA isolation for molecular characterization of circulating tumor cells (CTCs) from whole human blood